Correlation Between Aerovate Therapeutics and Codiak BioSciences
Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Codiak BioSciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Codiak BioSciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Aerovate Therapeutics and Codiak BioSciences, you can compare the effects of market volatilities on Aerovate Therapeutics and Codiak BioSciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Codiak BioSciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Codiak BioSciences.
Diversification Opportunities for Aerovate Therapeutics and Codiak BioSciences
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Aerovate and Codiak is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Codiak BioSciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Codiak BioSciences and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Codiak BioSciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Codiak BioSciences has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Codiak BioSciences go up and down completely randomly.
Pair Corralation between Aerovate Therapeutics and Codiak BioSciences
If you would invest (100.00) in Codiak BioSciences on September 3, 2024 and sell it today you would earn a total of 100.00 from holding Codiak BioSciences or generate -100.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 0.0% |
| Values | Daily Returns |
Aerovate Therapeutics vs. Codiak BioSciences
Performance |
| Timeline |
| Aerovate Therapeutics |
| Codiak BioSciences |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Aerovate Therapeutics and Codiak BioSciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Aerovate Therapeutics and Codiak BioSciences
The main advantage of trading using opposite Aerovate Therapeutics and Codiak BioSciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Codiak BioSciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Codiak BioSciences will offset losses from the drop in Codiak BioSciences' long position.| Aerovate Therapeutics vs. DiaMedica Therapeutics | Aerovate Therapeutics vs. Lyra Therapeutics | Aerovate Therapeutics vs. Centessa Pharmaceuticals PLC |
| Codiak BioSciences vs. Sabre Corpo | Codiak BioSciences vs. RCS MediaGroup SpA | Codiak BioSciences vs. Ecoloclean Industrs | Codiak BioSciences vs. Here Media |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |